Inveresk Research Group Inc. (Nasdaq: IRGI) has appointed Vanessa Chang as a director of the company and member of its audit committee effective immediately.

Chang is also an independent member of the board of directors and chairperson of the audit committee for New Perspective Fund (NYSE: NPF), a $20 billion global mutual fund advised by Capital Research and Management Company.

Previously, Chang was chief executive officer and founder of, an online dispute resolution services company. Prior to that, she was a senior vice president of Secured Capital Corp., a real estate investment bank, and a Partner at KPMG LLP.

Inveresk is a provider of drug development services to companies in the pharmaceutical and biotechnology industries. Through its pre-clinical and clinical business segments, the company offers a broad range of drug development services,

Based in Cary, Inveresk says it is one of a small number of drug development services companies currently providing a comprehensive range of pre-clinical and clinical development services on a world-wide basis. The company’s client base includes major pharmaceutical companies in North America, Europe and Japan.